TY  - JOUR 
AU  - Santos, J.R.
AU  - Domingo, P.
AU  - Portilla, J.
AU  - Gutiérrez, F.
AU  - Imaz, A.
AU  - Vilchez, H.
AU  - Curran, A.
AU  - Valcarce Pardeiro, Nieves
AU  - Payeras, A.
AU  - Bernal, E.
AU  - Montero-Alonso, M.
AU  - Yzusqui, M.
AU  - Clotet, B.
AU  - Videla, S.
AU  - Moltó, J.
AU  - Paredes, R.
PY  - 2023
SN  - 2328-8957
UR  - http://hdl.handle.net/20.500.11940/21001
AB  - Background. Suppressed patients with drug-resistant HIV-1 require effective and simple antiretroviral therapy to maintain treatment adherence and viral suppression. Methods. This randomized, open-label, noninferiority, multicenter pilot study involved...
LA  - eng
TI  - A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
DO  - 10.1093/ofid/ofad542
T2  - Open Forum Infectious Diseases
KW  - AS Ferrol
KW  - CHUF
VL  - 10
ER  -